Germline genetic variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA are associated with pathologic complete response to bevacizumab in breast cancer patients

Issam Makhoul, Valentina K. Todorova, Eric R. Siegel, Stephen W. Erickson, Ishwori Dhakal, Vinay R. Raj, Jeannette Y. Lee, Mohammed S. Orloff, Robert J. Griffin, Ronda S. Henry-Tillman, Suzanne Klimberg, Laura F. Hutchins, Susan A. Kadlubar

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Germline genetic variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA are associated with pathologic complete response to bevacizumab in breast cancer patients'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Neuroscience

Immunology and Microbiology